DK1294381T3 - Neurobeskyttende 7-beta-hydroxysteroider - Google Patents

Neurobeskyttende 7-beta-hydroxysteroider

Info

Publication number
DK1294381T3
DK1294381T3 DK01945490T DK01945490T DK1294381T3 DK 1294381 T3 DK1294381 T3 DK 1294381T3 DK 01945490 T DK01945490 T DK 01945490T DK 01945490 T DK01945490 T DK 01945490T DK 1294381 T3 DK1294381 T3 DK 1294381T3
Authority
DK
Denmark
Prior art keywords
hydroxysteroids
neuroprotective
beta
hydroxy
steroids
Prior art date
Application number
DK01945490T
Other languages
Danish (da)
English (en)
Inventor
Ernst Wuelfert
Ashley Ker Pringle
Lars Eric Sundstrom
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Application granted granted Critical
Publication of DK1294381T3 publication Critical patent/DK1294381T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01945490T 2000-06-29 2001-06-29 Neurobeskyttende 7-beta-hydroxysteroider DK1294381T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0016027A GB2363984A (en) 2000-06-29 2000-06-29 Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
PCT/GB2001/002929 WO2002000224A1 (en) 2000-06-29 2001-06-29 Neuroprotective 7-beta-hydroxysteroids

Publications (1)

Publication Number Publication Date
DK1294381T3 true DK1294381T3 (da) 2005-10-31

Family

ID=9894710

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01945490T DK1294381T3 (da) 2000-06-29 2001-06-29 Neurobeskyttende 7-beta-hydroxysteroider

Country Status (23)

Country Link
US (2) US20030186953A1 (cs)
EP (1) EP1294381B1 (cs)
JP (1) JP2004501195A (cs)
KR (1) KR100829490B1 (cs)
CN (1) CN100441189C (cs)
AT (1) ATE303152T1 (cs)
AU (2) AU2001267705B2 (cs)
CA (1) CA2414583C (cs)
CY (1) CY1105371T1 (cs)
CZ (1) CZ305306B6 (cs)
DE (1) DE60113112T2 (cs)
DK (1) DK1294381T3 (cs)
ES (1) ES2247141T3 (cs)
GB (1) GB2363984A (cs)
HK (1) HK1052299B (cs)
HU (1) HU229265B1 (cs)
IL (2) IL153540A0 (cs)
NO (1) NO332089B1 (cs)
PL (1) PL200698B1 (cs)
RU (1) RU2258511C2 (cs)
SI (1) SI1294381T1 (cs)
WO (1) WO2002000224A1 (cs)
ZA (1) ZA200210214B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
AU2003278744B2 (en) * 2002-08-28 2010-07-29 Harbor Biosciences, Inc. Therapeutic treatment methods
US20070231373A1 (en) * 2004-04-28 2007-10-04 Hunter-Fleming Limited Transdermal Steriod for Formulation
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
JP2008520730A (ja) * 2004-11-23 2008-06-19 セルジーン・コーポレーション 中枢神経系傷害の治療用ｊｎｋ阻害剤
CA2833976C (en) * 2006-11-21 2016-03-15 Umecrine Ab The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders
GB0623971D0 (en) * 2006-11-30 2007-01-10 Hunter Fleming Ltd Modulation of prostaglandin/cyclooxygenase metabolic pathways
AU2007327011A1 (en) * 2006-11-30 2008-06-05 Hunter-Fleming Limited Modulation of prostaglandin/cyclooxygenase metabolic pathways
CZ301216B6 (cs) * 2008-07-10 2009-12-09 Ústav organické chemie a biochemie Akademie ved CR, v. v. i. Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
DE102012001361A1 (de) 2012-01-24 2013-07-25 Linde Aktiengesellschaft Verfahren zum Kaltgasspritzen
US20160362442A1 (en) * 2015-06-10 2016-12-15 IronMag Labs Method For DHEA Enanthate Processing

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
FI953814A7 (fi) * 1993-03-09 1995-11-07 Univ Utah Res Found Menetelmät progressiivisen kudoskuolion, bakteerien translokaation, re perfuusiovaurion ja hengityksen vajaatoiminnan estämiseksi
PL185523B1 (pl) * 1995-06-06 2003-05-30 Cocensys Inc Neuroaktywne steroidy z grupy pochodnych androstanu i pregnanu oraz kompozycja farmaceutyczna
GB2317826B (en) * 1995-08-29 1999-12-15 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
CN1222851A (zh) * 1996-04-09 1999-07-14 英国技术集团国际有限公司 7α－取代的类固醇用于治疗神经精神病、免疫或内分泌疾病的用途
ATE363908T1 (de) * 1996-04-09 2007-06-15 Univ Edinburgh Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen
DE69733655T2 (de) * 1996-08-27 2006-04-27 Praecis Pharmaceuticals, Inc., Cambridge beta-AMYLOID PEPTIDAGGREGATION REGULIERENDE PEPTIDE MIT D-AMINOSÄUREN
RU2142802C1 (ru) * 1997-02-13 1999-12-20 Обут Тимофей Александрович Гипотензивное средство
US6544972B1 (en) * 1997-09-25 2003-04-08 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO1999024400A1 (en) * 1997-11-10 1999-05-20 Vyrex Corporation Probucol esters and uses thereof
WO1999026630A1 (en) * 1997-11-24 1999-06-03 University Of Florida Research Foundation, Incorporated Testosterone inhibitors and use for the protection of neurons
AU3467699A (en) * 1998-04-14 1999-11-01 Pharmadigm, Inc. Method for reducing central nervous system impairment
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
DK1226155T3 (da) * 1999-11-02 2007-09-10 Bayer Schering Pharma Ag 18-nor-steroider som selektivt virksomme östrogener
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone

Also Published As

Publication number Publication date
AU2001267705B2 (en) 2005-08-18
HU229265B1 (en) 2013-10-28
KR20030034112A (ko) 2003-05-01
HUP0301317A3 (en) 2006-06-28
KR100829490B1 (ko) 2008-05-16
PL359105A1 (en) 2004-08-23
RU2258511C2 (ru) 2005-08-20
DE60113112D1 (de) 2005-10-06
GB0016027D0 (en) 2000-08-23
GB2363984A (en) 2002-01-16
CN100441189C (zh) 2008-12-10
HK1052299B (en) 2006-01-27
CA2414583A1 (en) 2002-01-03
IL153540A0 (en) 2003-07-06
AU6770501A (en) 2002-01-08
US20100130459A1 (en) 2010-05-27
SI1294381T1 (sl) 2006-04-30
DE60113112T2 (de) 2006-07-13
ATE303152T1 (de) 2005-09-15
WO2002000224A1 (en) 2002-01-03
ES2247141T3 (es) 2006-03-01
PL200698B1 (pl) 2009-01-30
NO332089B1 (no) 2012-06-18
CY1105371T1 (el) 2010-04-28
EP1294381A1 (en) 2003-03-26
HK1052299A1 (en) 2003-09-11
EP1294381B1 (en) 2005-08-31
IL153540A (en) 2008-07-08
CZ305306B6 (cs) 2015-07-22
ZA200210214B (en) 2004-03-17
US20030186953A1 (en) 2003-10-02
JP2004501195A (ja) 2004-01-15
CN1443071A (zh) 2003-09-17
CA2414583C (en) 2010-08-24
NO20026244L (no) 2003-02-27
HUP0301317A2 (hu) 2003-08-28
NO20026244D0 (no) 2002-12-27

Similar Documents

Publication Publication Date Title
LU92381I2 (fr) Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT)
LU92745I2 (fr) Nétupitant/Palonosétron et leurs dérivés pharmaceutiquement acceptables (AKYNZEOr)
DE50010609D1 (de) Sport-trainings-vorrichtung sowie sport-trainings-system
NO20002026L (no) Tilbaketrekkingssnelle for nøkler og lignende
LU92517I2 (fr) Delamanide et ses dérivés pharmaceutiquement acceptables
LU91501I2 (fr) Sugammadex et ses sels pharmaceutiquement acceptables-BRIDION
LU92513I2 (fr) Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi)
AU2000259008A1 (en) Flexible circuits with static discharge protection and process for manufacture
MXPA03004373A (es) Mascara para la cara extensible y retractil.
DE60010098D1 (de) 28-epirapaloge
DK1294381T3 (da) Neurobeskyttende 7-beta-hydroxysteroider
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20024598L (no) Farmasöytisk aktive pyrrolidinderivater
FI20000508L (fi) Murskain
ATE401897T1 (de) 7-hydroxyepiandrosteron mit neuroprotektiver wirkung
AU2001229439A1 (en) Bioconjugates and uses thereof
ID29716A (id) Peranti pelindung
DE10084991T1 (de) Gegen Pestizide schützende Gegenstände
NO20021475D0 (no) Vasopressinantagonist, formulering og fremgangsmåte
FI20010377L (fi) Suojakotelo mikrofoneja varten
FI991388A0 (fi) Karamurskain
DE59905993D1 (de) Abschaltkupplung
AU2002222093A1 (en) Goggles and masks
ES1045156Y (es) Dispositivo de proteccion y publicidad de cajas paletizadas.
AU2002327431A1 (en) Reticle protection and transport